Supplier of Injectable Medications (Vials, Lyophilized Powders)

This contract involves the supply of injectable pharmaceuticals specifically formulated as lyophilized powders that require reconstitution prior to administration. These medications are to be provided in single-dose vials intended for use in clinical research. The contract, managed by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, aims to secure a subcontractor capable of delivering these specialized pharmaceutical products in accordance with regulatory and quality standards suitable for clinical investigations. The solicitation was posted on May 4, 2026, with a response deadline set for May 15, 2026. It falls under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. While some details such as specific location for performance and point of contact are not provided, the contract emphasizes the importance of supplying sterile injectable products to support clinical research endeavors. This opportunity is critical for ensuring uninterrupted access to investigational medicinal products in a controlled and compliant environment.